Aegon N.V. (AGN.AS)
| Previous Close | 3.9420 |
| Open | 3.9270 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.7380 - 3.9270 |
| 52 Week Range | 3.7130 - 5.4200 |
| Volume | |
| Avg. Volume | 9,218,591 |
| Market Cap | 7.723B |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.22 (4.48%) |
| Ex-Dividend Date | Aug 23, 2022 |
| 1y Target Est | N/A |
- GlobeNewswire
Aegon publishes its 2022 Integrated Annual Report
The Hague, March 16, 2023 - Aegon N.V. today published its Integrated Annual Report 2022. The report provides an overview of its businesses, the company’s strategy and sustainability approach, and its financial and non-financial performance. The report also reflects on the key trends that influence Aegon's businesses and its stakeholders, and how these trends impact the way in which the company creates and shares value, today and in the future. To read more about Aegon’s purpose and other topics
- GlobeNewswire
Aegon hosts educational webinar on IFRS 17 and IFRS 9
The Hague, March 9, 2023 - Aegon will today host an educational webinar to outline its implementation of the accounting standards IFRS 17 and IFRS 9, which have become effective on January 1, 2023. IFRS 17 is the first international accounting standard for insurance contracts and aims to create more consistency and comparability between companies. While the new accounting standard will impact Aegon’s financial reporting, it will not impact its strategy, capital management approach, financial tar
- GlobeNewswire
Aegon reports fourth quarter 2022 results
Please click here to access all 4Q2022 results related documents. The Hague, February 9, 2023 - Acceleration of strategy execution and delivery on financial commitments Previously announced impairment loss from classifying Aegon the Netherlands as held for sale following the transaction with a.s.r. leads to net loss of EUR 2.4 billion for 4Q22 and EUR 2.5 billion for the full yearOperating result of EUR 488 million, a 4% increase compared with 4Q21. Benefits from expense savings, growth initiati
